Amphastar Pharma (AMPH) Tops Q1 EPS by 15c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. FIX
9. TSCO
10. BE

Go back to Amphastar Pharma (AMPH) Tops Q1 EPS by 15c

Amphastar Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2016

May 9, 2016 4:07 PM EDT

RANCHO CUCAMONGA, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the first quarter ended March 31, 2016.

First Quarter Highlights

Net revenues of $59.4 million for the first quarterGAAP net income of $2.5 million, or $0.05 per diluted share, for the first quarterAdjusted non-GAAP net income of $5.5 million, or $0.12 per diluted share, for the first quarter

Dr. Jack Zhang, Amphastars CEO, commented:  We are pleased to announce that we filed... More